Concepedia

Mark Dacey

MD

Statistics

Publications

6

Citations

380

H-Index

6

Active since

2011

Affiliations

Retina Associates(Current)

Colorado Retina Center

Smith-Kettlewell Eye Research Institute

University of Colorado Anschutz Medical Campus

Stanford University

Mark Dacey is an author at Retina Associates specializing in medicine, pharmacotherapy, and uveal disease.

Publications per year

2011–2024

6

Publications

6

Primary (Month-6) Outcomes of the STOP-Uveitis Study: Evaluating the Safety, Tolerability, and Efficacy of Tocilizumab in Patients With Noninfectious Uveitis

Yasir J. Sepah, Mohammad Ali Sadiq, David Chu et al. · American Journal of Ophthalmology · 2017 · 161 citations

Pharmacy, Immunology, Pharmacotherapy +10

Panuveitis following Vaccination for COVID-19

Lucy I. Mudie, Jon Zick, Mark Dacey et al. · Ocular Immunology and Inflammation · 2021 · 96 citations

Medicine, Infectious Diseases, Ophthalmology +14

Bilateral uveitis associated with fluoroquinolone therapy

David M. Hinkle, Mark Dacey, Efrem D. Mandelcorn et al. · Cutaneous and Ocular Toxicology · 2011 · 57 citations

Medicine, Ophthalmology, Pharmacotherapy +14

Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial

Nisha R. Acharya, Caleb D. Ebert, Nicole K. Kelly et al. · Trials · 2020 · 23 citations · Full text

Medicine, Immunology, Pharmacotherapy +16

Filgotinib in Active Noninfectious Uveitis

Sunil K. Srivastava, Timothy R. Watkins, Quan Dong Nguyen et al. · JAMA Ophthalmology · 2024 · 23 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +16

1–5 of 6